Navigation Links
Savient Pharmaceuticals Announces New Data Surrounding KRYSTEXXA® and the Impact of Refractory Chronic Gout at the American College of Rheumatology Meeting
Date:11/5/2011

hysicians and Rheumatologists: A Chart Review of 1,039 Patients with Gout In the United States
Presentation Number: 1035
Monday, November 7, 2011: 9:00 AM-6:00 PM
Poster Hall (McCormick Place Convention Center)

Gout Patient Burden Associated with Flares, Tophi, and Awareness of Uric Acid Levels In U.S. and E.U.
Presentation Number: 216
Sunday, November 6, 2011: 9:00 AM-6:00 PM
Poster Hall (McCormick Place Convention Center)

Economic Burden of Gout Patients Treated with Urate Lowering Therapy
Presentation Number: 2583
Wednesday, November 9, 2011: 10:00 AM
Oral presentation W 474 A (McCormick Place Convention Center)

ABOUT KRYSTEXXA® KRYSTEXXA® (pegloticase) is a PEGylated uric acid specific enzyme for administration by intravenous infusion for the treatment of refractory chronic gout (RCG) in adult patients. KRYSTEXXA became commercially available in the U.S. by prescription on December 1, 2010, and is the only U.S. Food and Drug Administration approved product specifically indicated for the treatment of RCG. KRYSTEXXA is not recommended for the treatment of asymptomatic hyperuricemia. For more information about KRYSTEXXA, please visit: http://www.krystexxa.com/.

IMPORTANT SAFETY INFORMATION ABOUT TREATMENT WITH KRYSTEXXA®KRYSTEXXA is not indicated for the treatment of asymptomatic hyperuricemia.  Patients who are at risk of having a condition known as G6PD deficiency should be screened by their physician prior to starting therapy with KRYSTEXXA. 

Possible side effects of KRYSTEXXA include:

  • Anaphylaxis which occurred in some patients treated with KRYSTEXXA. KRYSTEXXA should be administered in healthcare settings and by healthcare providers prepared to
    '/>"/>

  • SOURCE Savient Pharmaceuticals, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8

    Related medicine technology :

    1. Savient Pharmaceuticals Reports Third Quarter 2011 Financial Results
    2. Savient Pharmaceuticals to Hold Third Quarter 2011 Financial Results Conference Call on Thursday, November 3, 2011
    3. Savient Pharmaceuticals to Present at the Sixth Annual JMP Securities Healthcare Conference
    4. Savient Pharmaceuticals Names Kenneth J. Zuerblis Chief Financial Officer
    5. Savient Pharmaceuticals Announces Publication of Pivotal Phase III KRYSTEXXA® Data in JAMA Demonstrating Significant Benefits in Refractory Chronic Gout Patients
    6. Savient Pharmaceuticals to Present at the Wedbush Securities 2011 Life Sciences Management Access Conference
    7. Savient Pharmaceuticals Reports Second Quarter 2011 Financial Results
    8. Savient Pharmaceuticals to Hold Second Quarter 2011 Financial Results Conference Call on Thursday, August 4, 2011
    9. Savient Pharmaceuticals Marketing Authorization Application for KRYSTEXXA® Accepted for Review by European Medicines Agency
    10. Savient Pharmaceuticals Reports First Quarter 2011 Financial Results
    11. Savient Pharmaceuticals Submits European Marketing Authorization Application for KRYSTEXXA®
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:5/22/2015)... May 22, 2015  Amgen (NASDAQ: ... commenced termination of its participation in the ... (LON:AZN, STO:AZN and NYSE: AZN ).  ... development for patients with moderate-to-severe plaque psoriasis, ... was based on events of suicidal ideation ...
    (Date:5/22/2015)... HILL, N.C. , May 22, 2015 /PRNewswire/ ... critical to pharmaceutical brand recognition and success. ... LLC conducted a study to provide pharmaceutical and ... of investment (FTEs and budget) that are being ... Pharmaceutical and biotech marketing managers can utilize this ...
    (Date:5/22/2015)... 22, 2015 Electrophysiologist Kevin Makati, M.D. ... to Boston, MA to ... Heart Rhythm Society conference. These scientific sessions drew ... the ideas, people and technology that propel their ... hybrid, minimally invasive cardiac operation that combines the ...
    Breaking Medicine Technology:Amgen to terminate participation in co-development and commercialization of brodalumab 2Amgen to terminate participation in co-development and commercialization of brodalumab 3Amgen to terminate participation in co-development and commercialization of brodalumab 4Amgen to terminate participation in co-development and commercialization of brodalumab 5Effective Marketing Services Group Critical for Pharmaceutical Brand Recognition 2St. Joseph's Hospital Heart Institute Physician Presents at Heart Rhythm Society 2St. Joseph's Hospital Heart Institute Physician Presents at Heart Rhythm Society 3
    ...   " The   Obama administration will offer loans ... in adopting technology to improve healthcare quality." ... records . " What is Europe,s ... IT programmes and initiatives are currently taking place across the entire ...
    ... ? Sosei Group Corporation ("Sosei"; TSE Mothers ... Pharma Co., Ltd. ("Activus") is to receive a grant ... New Energy and Industrial Technology Development Organization (NEDO), an ... and Industry (METI) as a part of their FY2011 ...
    Cached Medicine Technology:Innovations in E-Health & Informatics Europe: The Need for a European EHealth Strategy 2Sosei to Receive Grant from NEDO's FY2011 Innovation Promotion Programme for Development of Innovative Ophthalmic Solutions 2Sosei to Receive Grant from NEDO's FY2011 Innovation Promotion Programme for Development of Innovative Ophthalmic Solutions 3
    (Date:5/25/2015)... 2015 ProDrop Light Show allows users ... light backdrops with a click of a mouse. Users have full ... all within Final Cut Pro X. , ProDrop Light Show gives ... zones, kaleidoscope and much more leaving infinite possibilities all within Final ... zones and text presets, users can apply their very own media ...
    (Date:5/25/2015)... TX (PRWEB) May 25, 2015 Decora Preset ... company ‘Leviton’ is now available on ‘The Hardware City.’ The ... user has to set a time and the related electronic ... When contacted a representative of the company said, “We are ... Hardware City.’ Now customers can buy Countdown Timer Switch in ...
    (Date:5/24/2015)... (PRWEB) May 24, 2015 Women’s ... to take pressure measurements in patients’ bladder and urethra. ... usually orders it if they have reported symptoms of ... , Women’s Excellence in Bladder Control is a ... urinary leakage or problems with overall control of their ...
    (Date:5/24/2015)... May 24, 2015 Indiana Fiber Network, ... announces Midwest Telecom of America, Inc. (MTA) has selected ... to Cory Childs, IFN Enterprise Sales Manager, fiber route ... “IFN’s fiber transport provides MTA with the diverse ... their Tier 1 Internet and voice carriers located at ...
    (Date:5/23/2015)... (PRWEB) May 23, 2015 On May ... powers of a youngster's yogic power learned through meditation ... Nithyananda Swami in Bangalore, India. , Yogamaatha, a nine-year-old ... than 50 high profile professionals attending the 2015 Business ... reading fluently -- blindfolded. , In a demonstration ...
    Breaking Medicine News(10 mins):Health News:Developers at Pixel Film Studios Release of ProDrop Light Show for Final Cut Pro X. 2Health News:Leviton's Decora 60 Minute Countdown Timer Available On ‘The Hardware City’ 2Health News:Indiana Fiber Network, LLC Enables Midwest Telecom of America with Fiber Route Diversity 2Health News:Nine-Year-Old Reads Blindfolded at Business Advocacy Summit 2Health News:Nine-Year-Old Reads Blindfolded at Business Advocacy Summit 3
    ... may have implications for labor anesthesia, orthopedics and more , ... holy grails of local anesthesia is the ability to achieve a ... function. Now, researchers at Children,s Hospital Boston have discovered an anesthetic ... work in humans as well as it did in rats, it ...
    ... , , Rare, but serious, liver ... Feb. 1 The U.S. Food and Drug Administration today ... disorder, has been reported in some HIV patients taking Videx/Videx ... Videx is an antiretroviral medicine first approved by the FDA ...
    ... projects will combat global diseases , INDIANAPOLIS , ... its next global cause, and its International Board of Trustees ... Neglected Tropical Diseases for their Neglected Tropical Diseases (NTDs) proposal; ... joint malaria proposal; and UNICEF for its proposal on maternal ...
    ... , LIVERMORE, Calif. , Feb. 1 ... news outlets have recently featured headline stories about a clinical ... not at all surprised by the attention this study is ... and Chief Operating Officer of Halt Medical, Inc., a medical ...
    ... The brain,s innate interest in the new and different ... to research published by the American Psychological Association. In ... place they got cocaine. Novelty could help ... for the many addicts with novelty-craving, risk-taking personalities, the ...
    ... that pandemic H1N1 influenza of swine origin has distinct means ... in the pathogenic severity of avian flu viruses. The ... Responses of the 2009 Pandemic H1N1 Influenza Virus in ex ... Tract," appears published online ahead of print in the April ...
    Cached Medicine News:Health News:Anesthetic Approach Stops Pain Without Affecting Motor Function 2Health News:Anesthetic Approach Stops Pain Without Affecting Motor Function 3Health News:FDA Announces Safety Risk Associated with HIV Drug 2Health News:Kiwanis Selects Three Finalists for Worldwide Service Project 2Health News:Kiwanis Selects Three Finalists for Worldwide Service Project 3Health News:Kiwanis Selects Three Finalists for Worldwide Service Project 4Health News:Novelty lures rats from cocaine-paired settings, hinting at new treatments for recovering addicts 2Health News:Novelty lures rats from cocaine-paired settings, hinting at new treatments for recovering addicts 3Health News:Of swine, birds and men -- pandemic H1N1 flu 2
    Smooth, round edges allow for safe manipulation within the eye. 1.1mm wide gradually tapers to .50 mm wide. 45, 1.1mm wide, gradually tapers to .50mm wide....
    Designed to lift corneal cap/flap during corneal lamellar surgery...
    Pre-expanded for convenience; no need to pre-soak and fan. Lint-free PVAmaterial...
    Angled 45, 9mm from end, Longer design from bend to tip allows for easier placement of viscoelastic to all meridians, Dome shape, extra smooth tip...
    Medicine Products: